Ian K. Wright - Concepedia

Concepedia

Author

Ian K. Wright

Queen's Medical Centre

Also Known As

I. K. Wright, I. Wright, I.K. Wright, Ian K. Wright, Ian Wright

23

Publications

1.1K

Citations

16

H-Index

27

Concepts

All Affiliations

Queen's Medical Centre Molecular Discovery (United Kingdom)

IK

About

Ian K. Wright is an author at Queen's Medical Centre specializing in medicine, social sciences, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	715
2	Social Sciences	6	6	630
3	Neuroscience	6	6	630
4	Anesthesia	1	1	66
5	Biochemistry	1	1	85

Ian K. Wright

×

16

Publications

1.1K

Citations

16

H-Index

	Year	Citations
Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze model of anxiety Ian K. Wright, N. Upton, C.A. Marsden Physiology & Behavior Experimental PsychopathologyPsychiatryBehavioral NeuroscienceIsolation-reared RatsBehavioural Pharmacology	1991	178
Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze Ian K. Wright, N. Upton, C.A. Marsden Psychopharmacology Neurobiological MechanismNeuropsychologyPsychiatryNeurophysiologyBehavioral Neuroscience	1992	135
Social isolation attenuates rat forebrain 5-HT release induced by KCl stimulation and exposure to a novel environment Mike Bickerdike, Ian K. Wright, Charles Alexandar Marsden Behavioural Pharmacology	1993	113
Effect of isolation rearing on 5-HT agonist-induced responses in the rat Ian K. Wright, Hammad Ismail, N. Upton, Psychopharmacology Behavioral NeuroscienceMedicineBehavioural PharmacologyPhysiologyBehavioral Pharmacology	1991	98
Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study Carol Routledge, J Gurling, Ian K. Wright, European Journal of Pharmacology Vivo Microdialysis StudyNeurochemical ProfileNeurophysiologyMedicinePhysiology	1993	88
Agmatine recognizes ?2-adrenoceptor binding sites but neither activates nor inhibits ?2-adrenoceptors Darawan Pinthong, Ian K. Wright, Christian Hammer, Naunyn-Schmiedeberg s Archives of Pharmacology Adrenal GlandSignal TransductionBiochemistryG Protein-coupled ReceptorMedicine	1995	85
Effects of a selective 5‐HT<sub>2</sub> agonist, DOI, on 5‐HT neuronal firing in the dorsal raphe nucleus and 5‐HT release and metabolism in the frontal cortex Ian K. Wright, Jeni C. Garratt, C.A. Marsden British Journal of Pharmacology	1990	81
Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze Ian K. Wright, Michael P. Heaton, N. Upton, Psychopharmacology Psychoactive DrugNeurophysiologyMedicineVarious Serotonergic AgentsPsychopharmacology	1992	66
Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI Jeni C. Garratt, Emma J. Kidd, Ian K. Wright, European Journal of Pharmacology Molecular PharmacologyMolecular NeuroscienceNeurophysiologyMedicinePhysiology	1991	65
One-year sustained efficacy of erenumab in episodic migraine Peter J. Goadsby, Uwe Reuter, Yngve Hallström, Neurology	2020	61

Page 1